VerifiedBiotechnology Research· Founded 2018

Trexbio

TRexBio is a clinical-stage biotechnology company discovering and developing immunoregulatory medicines based on tissue Treg biology by leveraging cutting-edge computational biology tools, a focus on human tissue, and deep immunobiology expertise. The company’s Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention. Our lead program TRB-061, currently in a Ph1 clinical trial for atopic dermatitis, is a novel TNFR2-selective agonist designed to activate and expand effector Tregs in the tissue and restore immune balance in inflammatory diseases. TRexBio is headquartered in South San Francisco, California. For more info, visit

7-day free trial · no credit card

South San Francisco, United States57(11 to 50)$1M to <$10M2018trex.bio LinkedIn

Verified contacts

52

available on Kipplo

LinkedIn employees

57

11 to 50 range

Open roles

—

no listings

Distinct roles

28

indexed titles

Tech stack

1

tools in use

Monthly traffic

820

organic / mo

Sign up free to see all 52 verified contacts at Trexbio

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

52 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 52 verified contacts

Top roles at Trexbio

28 distinct titles indexed · top 10 shown.

5scientist i
4scientist
3computational biologist
3principal scientist
3scientist ii
2associate scientist ii
2director
2senior scientist
1()
1associate director
+18more titles

Sign up to unlock all 52 contacts at Trexbio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 52 verified contacts at Trexbio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Trexbio | Kipplo Discover